Pharmaceutical companies call for changes to investment clawback on clinical trials
Pharmaceutical companies are requesting stronger incentives for conducting clinical trials following the issuance of a new Joint Ministerial Decision.
Pharmaceutical companies are asking the competent ministries to establish a stronger incentive framework to conduct more clinical trials in the country. This intervention comes following the issuance of Joint Ministerial Decision B1b,B2a,b/oik.4086 concerning the investment clawback.
Sources
Naftemporiki24 September 2026
Mykonea reporting.
